Pulmonary hypertension in extremely low birth weight infants: characteristics and outcomes

Wambui Waruingi1, Maroun Jean Mhanna

  • 1Department of Pediatrics, Division of Neonatology, Metro Health Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, 44109, USA.

Insights

Pulmonary arterial hypertension (PAH) in extremely low birth weight (ELBW) infants is linked to maternal drug use and severe lung disease. These infants face higher mortality rates and prolonged ventilation needs.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Pulmonary arterial hypertension (PAH) is a serious condition affecting infants.
  • Extremely low birth weight (ELBW) infants are particularly vulnerable to respiratory complications.
  • Understanding PAH in ELBW infants is crucial for improving outcomes.

Purpose of the Study:

  • To investigate the characteristics of pulmonary arterial hypertension (PAH) in extremely low birth weight (ELBW) infants.
  • To determine the outcomes associated with PAH in this vulnerable population.

Main Methods:

  • A retrospective case-control study was conducted.
  • Data from ELBW infants admitted to a level III NICU between 2003 and 2010 were analyzed.
  • Infants diagnosed with PAH were matched with control infants.

Main Results:

  • PAH was diagnosed in 6.4% of ELBW infants.
  • Infants with PAH were smaller at birth and had higher rates of maternal illicit drug exposure.
  • PAH was associated with longer mechanical ventilation, severe bronchopulmonary dysplasia, and increased NICU mortality.

Conclusions:

  • PAH in ELBW infants is associated with maternal illicit drug use.
  • Prolonged mechanical ventilation and severe bronchopulmonary dysplasia are significant factors.
  • PAH in ELBW infants leads to a substantial increase in early mortality.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
906
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
39
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
817
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
39